Benchmark Holdings (BMK)

Sector:

Pharma and Biotech

24.20p
   
  • Change Today:
      0.40p
  • 52 Week High: 45.85
  • 52 Week Low: 17.70
  • Currency: UK Pounds
  • Shares Issued: 741.51m
  • Volume: 1,014,554
  • Market Cap: £179.44m

Benchmark delivers better-than-expected performance in Q4

By Iain Gilbert

Date: Monday 24 Oct 2022

LONDON (ShareCast) - (Sharecast News) - Biotechnology business Benchmark said on Monday that following "strong" Q3 results and "a continued positive performance" throughout the rest of the fiscal year, it had experienced better-than-expected trading across its three business areas in Q4.
Benchmark said its genetics unit ended the year "above management expectations", benefitting from "strong demand" for its salmon eggs in Q4, while its advanced nutrition division saw "a continuation of the excellent performance throughout the year", delivering revenues ahead of plan across all product areas.

In health, revenues from the AIM-listed group's Ectosan Vet and CleanTreat products reflected increased activity and customer uptake ahead of the main sea lice treatment season.

As a result, Benchmark stated it now expects to report adjusted underlying earnings in the range of £30.0m-£31.0m - ahead of consensus market expectations of £27.7m.

However, Benchmark, which successfully refinanced its outstanding NOK 850.0m (£70.87m) secured bond through the issue of an unsecured NOK 750.0m (£62.56m) green bond, warned that despite "positive trends and developments", heightened volatility in debt and currency markets had impacted financing costs.

In addition to this, Benchmark also cautioned that it had one-off costs associated with the redemption of the outstanding NOK 850.0m bond, which amounts to roughly £2.5m. Net debt, excluding lease liabilities, as of 30 September was £47.5m and cash was £36.4m following the refinancing.

As of 0835 BST, Benchmark shares were up 3.05% at 38.90p.





Reporting by Iain Gilbert at Sharecast.com

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

BMK Market Data

Currency UK Pounds
Share Price 24.20p
Change Today 0.40p
% Change 1.68 %
52 Week High 45.85
52 Week Low 17.70
Volume 1,014,554
Shares Issued 741.51m
Market Cap £179.44m

BMK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
64.45% above the market average64.45% above the market average64.45% above the market average64.45% above the market average64.45% above the market average
95.74% above the sector average95.74% above the sector average95.74% above the sector average95.74% above the sector average95.74% above the sector average
Price Trend
75.67% below the market average75.67% below the market average75.67% below the market average75.67% below the market average75.67% below the market average
44.68% below the sector average44.68% below the sector average44.68% below the sector average44.68% below the sector average44.68% below the sector average
Income Not Available
Growth
57.22% below the market average57.22% below the market average57.22% below the market average57.22% below the market average57.22% below the market average
80.65% below the sector average80.65% below the sector average80.65% below the sector average80.65% below the sector average80.65% below the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

BMK Dividends

No dividends found

Trades for 27-May-2025

Time Volume / Share Price
16:15 50,000 @ 23.98p
16:35 16 @ 24.20p
16:35 15 @ 24.20p
16:35 1 @ 24.20p
15:33 34,933 @ 23.88p

BMK Key Personnel

CFO Septima Maguire
CEO Trond Williksen
Chair Tripp Lane

Top of Page